Infinium Pharmachem Balance Sheet Health
Financial Health criteria checks 4/6
Infinium Pharmachem has a total shareholder equity of ₹552.4M and total debt of ₹307.4M, which brings its debt-to-equity ratio to 55.6%. Its total assets and total liabilities are ₹1.0B and ₹467.2M respectively. Infinium Pharmachem's EBIT is ₹155.0M making its interest coverage ratio 5.7. It has cash and short-term investments of ₹127.6M.
Key information
55.6%
Debt to equity ratio
₹307.39m
Debt
Interest coverage ratio | 5.7x |
Cash | ₹127.65m |
Equity | ₹552.37m |
Total liabilities | ₹467.18m |
Total assets | ₹1.02b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: INFINIUM's short term assets (₹820.7M) exceed its short term liabilities (₹377.1M).
Long Term Liabilities: INFINIUM's short term assets (₹820.7M) exceed its long term liabilities (₹90.1M).
Debt to Equity History and Analysis
Debt Level: INFINIUM's net debt to equity ratio (32.5%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if INFINIUM's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: INFINIUM's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: INFINIUM's interest payments on its debt are well covered by EBIT (5.7x coverage).